DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  

Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

The Medicines Company 

8 Sylvan Way

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-290-6000 Fax: 973-656-9898


SEARCH JOBS






Collaborations

UCB, Inc.  Contract manufacturing of Bivalirudin peptide active ingredient





 Company News
The Medicines Company (MDCO) To Announce First Quarter 2014 Financial Results On Wednesday, April 23, 2014 4/10/2014 10:24:30 AM    More...
FDA Accepts The Filing Of The Medicines Company (MDCO)'s US Biologic License Application For Fibrocaps Hemostatic Agent 4/4/2014 9:59:19 AM    More...
The Medicines Company (MDCO) Release: Update On Angiomax® (Bivalirudin) Patent Litigation 4/1/2014 11:01:28 AM    More...
Analysis Of EUROMAX And HORIZONS-AMI Trials Of The Medicines Company (MDCO)'s Angiomax(R) (Bivalirudin) Presented At American College of Cardiology14 3/31/2014 8:53:35 AM    More...
The Medicines Company (MDCO) To Participate In 2014 Barclays Global Healthcare Conference 3/7/2014 9:40:28 AM    More...
European Medicines Agency Accepts Marketing Authorization Application For The Medicines Company (MDCO)'s Oritavancin 2/27/2014 9:52:42 AM    More...
The Medicines Company (MDCO) Reports Fourth Quarter And Full Year 2013 Financial Results 2/20/2014 10:01:38 AM    More...
The Medicines Company (MDCO) To Participate In Upcoming Healthcare Investor Conferences 2/20/2014 9:29:30 AM    More...
FDA Accepts Filing Of The Medicines Company (MDCO)'s New Drug Application For Intravenous Antibiotic Oritavancin With Priority Review 2/19/2014 10:50:48 AM    More...
The Medicines Company (MDCO) Stock Trading Halted Today 2/12/2014 9:44:55 AM    More...
12345678910...